0001181431-12-017850.txt : 20120315
0001181431-12-017850.hdr.sgml : 20120315
20120315212747
ACCESSION NUMBER: 0001181431-12-017850
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120313
FILED AS OF DATE: 20120315
DATE AS OF CHANGE: 20120315
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Peroutka Stephen J
CENTRAL INDEX KEY: 0001534573
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33438
FILM NUMBER: 12695608
MAIL ADDRESS:
STREET 1: 24660 CABRILLO STREET
CITY: CARMAL
STATE: CA
ZIP: 93923
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NeurogesX Inc
CENTRAL INDEX KEY: 0001385830
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943307935
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2215 BRIDGEPOINTE PARKWAY
STREET 2: SUITE 200
CITY: SAN MATEO
STATE: CA
ZIP: 94404
BUSINESS PHONE: 650-358-3300
MAIL ADDRESS:
STREET 1: 2215 BRIDGEPOINTE PARKWAY
STREET 2: SUITE 200
CITY: SAN MATEO
STATE: CA
ZIP: 94404
4
1
rrd339011.xml
FORM 4
X0304
4
2012-03-13
0
0001385830
NeurogesX Inc
NGSX
0001534573
Peroutka Stephen J
C/O NEUROGESX, INC.,
2215 BRIDGEPOINTE PARKWAY, SUITE 200
SAN MATEO
CA
94404
0
1
0
0
Vice President and CMO
Stock Option (right to buy)
0.48
2012-03-13
4
A
0
175000
0
A
2013-03-13
2022-03-13
Common Stock
175000
175000
D
Stock Option (right to buy)
0.48
2012-03-13
4
A
0
175000
0
A
2014-03-13
2022-03-13
Common Stock
175000
175000
D
The option grant shares are granted under the 2007 Stock Plan and shall vest as follows: one-hundred percent (100%) of the total number of shares subject to the option grant shall become exercisable on March 13, 2013, subject to the grantee's continued service relationship with the Company
The option grant shares are granted under the 2007 Stock Plan and shall vest as follows: one-hundred percent (100%) of the total number of shares subject to the option grant shall become exercisable on March 13, 2014 or upon the attainment of the Company's milestone; such milestone must be attained by December 31, 2012 or the shares shall not become exercisable until March 13, 2014, subject to the grantee's continued service relationship with the Company.
/s/ Stephen Ghiglieri as Attorney in Fact for Stephen J. Peroutka
2012-03-15